On May 25, 2022, the Board of GoHealth, Inc. appointed David Fisher as a Class I director to fill the vacancy created by Helene D. Gayle, who resigned from the Board, in each case effective as of May 25, 2022. Mr. Fisher will serve with a term expiring at the Company's annual meeting of stockholders to be held in 2024, and until his successor is duly elected and qualified or his earlier death, disqualification, resignation or removal. In addition, Mr. Fisher was appointed to the Audit Committee of the Board and will serve as its chair, effective immediately.

Mr. Fisher's position on the Audit Committee will result in three independent directors serving on such committee in accordance with NASDAQ requirements. Mr. Fisher was appointed to the Board as the independent" designee of NVX Holdings, Inc. pursuant to the terms of the Stockholders Agreement dated July 15, 2020.